The Food and Drug Administration (FDA) has approved Avtozma ® (tocilizumab-anoh), a biosimilar to Actemra ® (tocilizumab), in both intravenous (IV) and subcutaneous (SC) formulations.

The biosimilar will be available in both subcutaneous and intravenous formulations and has nearly all the same indications as ...

Anyone can develop an inflammation but in some people it may be silent Therefore getting proper tests can help confirm your ...

Achieved statistical significance on primary endpoint at Week 12 on mean change from baseline DAS-28 CRP across all rosnilimab doses vs. placebo; Achieved statistical significance ...

SAN FRANCISCO -- The pediatric Crohn's disease exclusion diet was associated with clinical remission for children with good ...

The FDA has approved a third biosimilar for tocilizumab, called Avtozma, the second such biosimilar to be available in both intravenous and subcutaneous formulations, according to a press release.

Patients with axSpA and early-stage hypertension face elevated risks for CVEs, likely due to their high inflammatory burden.

The C-reactive protein level was elevated (119 mg per liter; normal value, <10), as was the erythrocyte sedimentation rate (42 mm per hour; normal value, <15). Blood testing for HIV antigen and ...

The coprimary endpoints were the mean change from baseline in disease activity score 28 using erythrocyte sedimentation rate (DAS28-ESR) at week 12 and week 24. Findings showed the estimated ...

Understand RA from early to advanced stages. Explore symptoms, treatments, and lifestyle tips to manage rheumatoid arthritis ...

Mum Anne-Marie had to demand a print-out of the blood results, Google the results herself and pay for a private appointment before Bebe was diagnosed ...